Satellos Bioscience Schedules 11:30 a.m. ET April 21 Conference Presentation
Satellos Bioscience will present at Bloom Burton & Co. Healthcare Conference on April 21 in Toronto, with CEO Frank Gleeson at 11:30 a.m. ET and CFO Liz Williams in one-on-ones. A webcast and replay via website provide investors access before Phase II SAT-3247 trial data in Duchenne muscular dystrophy.
1. Conference Participation Details
Satellos Bioscience is scheduled to deliver a presentation at the Bloom Burton & Co. Healthcare Investor Conference on April 21 at the Metro Toronto Convention Centre in Toronto. CEO Frank Gleeson will speak at 11:30 a.m. ET and CFO Liz Williams will conduct one-on-one investor meetings throughout the event.
2. Webcast Access and Investor Impact
Investors can view the live webcast and replay via the company’s website, offering direct insight into Satellos’ strategy ahead of Phase II trial readouts for its oral SAT-3247 candidate targeting Duchenne muscular dystrophy. The conference appearance may boost visibility among biotech investors before key clinical data milestones.